Chinese herbal capsule for treating cough variant asthma

Abstract

The invention discloses a Chinese herbal capsule for treating cough variant asthma. The Chinese herbal capsule is prepared from the following traditional Chinese medicinal materials by weight: 7 partsof the leaf of Cassia siamea, 6 parts of common alstonia leaves, 5 parts of Rhizoma Zingiberis, 5 parts of Herba Epimedii, 6 parts of the herb of Asclepias curassavica, 8 parts of scoliid honeycomb,6 parts of the dried roots and stems of Heteropanax fragrans, 6 parts of the fruit or seed of pistachio, 6 parts of the herb of Dregea sinensis, 5 parts of Chinese ilex leaves, 5 parts of licorice roots, 6 parts of divaricate saposhnikovia roots, 6 parts of Poria cocos, 6 parts of the dried tuber of Pinellia ternate, 6 parts of dried orange peel, 6 parts of pseudostellaria root, 6 parts of Radix Asparagi, 6 parts of apricot kernels, 6 parts of root of Radix Scutellariae, 6 parts of root of the root of Lobelia pleotricha Diels and 6 parts of root of mulberry bark. Clinical experiments prove that through reasonable combination of the traditional Chinese medicinal materials, the prepared Chinese herbal capsule is beneficial for treatment of cough variant asthma, can effectively reduce recurrence of cough variant asthma and achieves good integral adjusting and long-term treatment effects.

Description

technical field [0001] The invention relates to a traditional Chinese medicine capsule, in particular to a traditional Chinese medicine capsule for treating cough variant asthma. Background technique [0002] In recent years, due to environmental and climatic factors, the incidence of cough-variant asthma has been on the rise. Because the symptoms are not typical, it is easy to cause misdiagnosis and mistreatment in clinical practice. This disease has been highly valued by Chinese and Western medicine experts. At present, there are no relatively clear diagnostic criteria and effective treatment options at home and abroad. Western medicine mainly uses hormones, B2 receptor agonists and theophylline drugs for symptomatic treatment, which has a certain effect on symptom control, but due to side effects, compliance is relatively low. Poor, so the diagnosis and treatment of the disease caused some difficulties. Due to the various causes of cough-variant asthma and the high incid...

AI Technical Summary

Problems solved by technology

In view of the complex interaction of various active ingredients of various Chinese medicinal materials in the body, changes in the pharmacokinetics and pharmacodynamics of various drugs in the body will have various effects on the interaction between drugs. When used in combination, it may not only produce synergistic drug effects, but also may produce antagonistic effects, which will lead to weakening of drug therapeutic effect or treatment failure. Some drugs in combination will also increase drug toxicity and cause adverse reactions; Enhanced, but when the therapeutic effect is excessively enhanced, it will exceed the body's ability to tolerate it, and it can also cause adverse reactions and even endanger patients.

Some of the research is to prepare traditional Chinese medicine prescriptions in order to treat cough-variant asthma. The most common problem is that the compatibility of the prescriptions is unreasonable, and it is often only based on the individual functions and indications of some single or compound medicines and some pharmacodynamic indicators. According to the theory of traditional Chinese medicine, the taste of prescriptions can be added or subtracted at will, resulting in unreasonable prescriptions, which contradicts the theory of traditional Chinese medicine.